Black Bird Biotech, Inc. (OTCMRKT: BBBT) provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treat, CBD-infused personal care products, and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program.
5 Practical Reasons Black Bird Biotech, Inc Could Be The Next Penny Stock Success Story:
- Black Bird Biotech is an under-the-radar company that has a very small market cap. As of 4/27/2022 the company’s market cap is less than $3 million dollars according to Yahoo Finance.
- The company has accelerated its planned 2022 sales and marketing efforts that are intended to bring much-needed crop protection to the dynamic cann-a-bis industry, one that is expected to grow to $45 billion by 2025.
- The company’s flagship product MiteXstream™ eradicates mites and similar pests, including spider mites in cann-a-bis and many other agricultural crops and eliminates molds and mildews.
- The company has focused marketing efforts on potential large customers across the agricultural spectrum, including, in addition to large cann-a-bis grows, coffee farms ($20 billion in global sales annually), vineyards ($4.5 billion in U.S. sales annually) and plant and flower farms ($16 billion in U.S. sales annually).
- The company is uniquely positioned in a massive and growing market. The Biopesticides market is expected to reach $33 billion according to a recent Allied Market Research report.
Discover Why this Company Could Be About To Dominate the market. This is the perfect add to watch-list stock and do your due diligence.
This business has huge potential, so check out this article for a further analysis on the company.
…
Disclaimer: “This User has been paid $200USD by a third party to provide coverage on 06/20-24/2022 for Black Bird Biotech, Inc. (BBBT).”
Leave a Reply